Rafferty Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
13,413
+2,343
| +21% | +$21.7K | ﹤0.01% | 1064 |
|
|
2025
Q1 | $81.1K | Sell |
11,070
-4,152
| -27% | -$30.4K | ﹤0.01% | 1050 |
|
|
2024
Q4 | $130K | Sell |
15,222
-3,209
| -17% | -$27.4K | ﹤0.01% | 1117 |
|
|
2024
Q3 | $160K | Sell |
18,431
-17,289
| -48% | -$150K | ﹤0.01% | 1117 |
|
|
2024
Q2 | $244K | Buy |
+35,720
| New | +$244K | ﹤0.01% | 1093 |
|
|
2023
Q4 | – | Sell |
-11,837
| Closed | -$37.2K | – | 1091 |
|
|
2023
Q3 | $37.2K | Buy |
+11,837
| New | +$37.2K | ﹤0.01% | 1070 |
|
|
2022
Q1 | – | Sell |
-20,022
| Closed | -$140K | – | 1296 |
|
|
2021
Q4 | $140K | Buy |
20,022
+3,988
| +25% | +$27.9K | ﹤0.01% | 1243 |
|
|
2021
Q3 | $160K | Buy |
16,034
+3,171
| +25% | +$31.6K | ﹤0.01% | 1200 |
|
|
2021
Q2 | $182K | Buy |
+12,863
| New | +$182K | ﹤0.01% | 1237 |
|